␥-Secretase is the protease responsible for amyloid ␤ peptide release and is needed for Notch, N-Cadherin, and possibly other signaling pathways. The protease complex consists of at least four subunits, i.e., Presenilin, Aph1, Pen2, and Nicastrin. Two different genes encode Aph1A and Aph1B in man. A duplication of Aph1B in rodents has given rise to a third gene, Aph1C. Different mixes of ␥-secretase subunits assemble in at least four human and six rodent complexes but it is not known whether they have different activities in vivo. We report here the inactivation of the three Aph1 genes in mice. Aph1A ؊/؊ embryos show a lethal phenotype characterized by angiogenesis defects in the yolk sac, neuronal tube malformations, and mild somitogenesis defects. Aph1B ؊/؊ or C ؊/؊ or the combined Aph1BC ؊/؊ mice (which can be considered as a model for total Aph1B loss in human) survive into adulthood. However, Aph1BC ؊/؊ deficiency causes a mild but significant reduction in amyloid ␤ percursor protein processing in selective regions of the adult brain. We conclude that the biochemical and physiological repercussions of genetically reducing ␥-secretase activity via the different Aph1 components are quite divergent and tissue specific. Our work provides in vivo evidence for the concept that different ␥-secretase complexes may exert different biological functions. In the context of Alzheimer's disease therapy, this implies the theoretical possibility that targeting specific ␥-secretase subunit combinations could yield less toxic drugs than the currently available general inhibitors of ␥-secretase activity.
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Alzheimer ͉ intramembrane cleavage ͉ Presenilin ͉ knockout T he multimolecular complex ␥-secretase cleaves proteins in their transmembrane domain. The complex consists of at least four subunits called Presenilin (Psen), Nicastrin (Nct), Pen2, and Aph1 (1) (2) (3) . The Psens provide the catalytic subunits of the complex (4) , although the precise functional contribution of the other subunits remains to be clarified. Mutations in the genes encoding presenilin 1 (PSEN1) or its homologue presenilin 2 (PSEN2) cause familial Alzheimer's disease (5, 6) . Besides amyloid ␤ (A␤) precursor protein (APP), ␥-secretase cleaves an increasing list of type I transmembrane proteins including Notch (7) and N-Cadherin (8) (for a full review, see ref. 9) .
Until now, ␥-secretase has largely been considered as a homogenous activity, but especially in mammals the situation is probably more complicated (10) . Two different Psen genes and two (human) or three (rodent) Aph1 genes that can be alternatively spliced have been identified. Aph1A or Aph1B and Psen1 or Psen2 are incorporated in a mutually exclusive way into different complexes as demonstrated recently, providing formal proof that at least four different complexes in man (and six in mouse) can be generated (11, 12) . The question remains however whether those different complexes have also different physiological functions. Because ␥-secretase is considered a potential drug target in Alzheimer's disease, a better understanding of the heterogeneity of this enzymatic activity is also of considerable medical importance. In this regard, Aph1 is highly interesting because, like Psen, it is a variable component of the ␥-secretase complex. Loss of function of the single genes in Caenorhabditis elegans (13, 14) , and Drosophila melanogaster (15) causes Notch signaling deficiencies. It is not known, however, to what extent the three Aph1 genes contribute to ␥-secretase signaling in Mus musculus and to what extent they are involved in APP processing in the brain. Here, we address this question by a genetic approach, inactivating the three known Aph1 genes in mice.
Materials and Methods
For more detailed information, see Supporting Text, which is published as supporting information on the PNAS web site.
Generation of Aph1 Knockout Mice. Conditionally targeted (Aph1A and -C) or classically targeted (Aph1B) mice were generated as detailed in Supporting Text. Animals carrying a null allele were obtained after breeding with transgenic mice expressing a Pgk driven Cre-recombinase. Determinations of the genotypes of the floxed or knockout mice or yolk sac of embryos were done by Southern blotting or PCR analysis.
Histology. Mice and embryos beyond embryonic day 14 (E14) were perfused via the left ventricle with either 6% glutaraldehyde or Bouin's solution diluted 1:4 in PBS or with 10% neutral buffered formaline. Younger embryos (E8.5-E13.5) were fixed by immersion. Serial sections (7 m) were cut, and the central sections of each series were stained with hematoxylin and eosin for standard light microscopy. Adjacent sections were used for immunohistological screening. A tyramide-based signal amplification technique (NEN-Dupont) was applied. For transmission and scanning EM, embryos were fixed in 6% glutaraldehyde and 2% OsO 4 . Postfixed embryos were dehydrated and then embedded in Araldite. For scanning EM, postfixed specimens were dehydrated, equilibrated with 100% acetone, and dried in a Polaron CPD 7501 critical point dryer by using liquid carbon dioxide. After mounting, gold coating (''sputtering'') was done with an Agar automatic coater. Mouse embryonic fibroblast (MEF) cultures were derived from dissociated Aph1-deficient mouse embryos and littermate controls (16, 17) . Subconfluent MEF cell lines were infected with recombinant adenovirus with a multiplicity of infection of 500
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Abbreviations: A␤, amyloid ␤; APP, A␤ precursor protein; En, embryonic day n; MEF, mouse embryonic fibroblast; CTF, C-terminal fragment. (18) . Control infections were done with recombinant adenovirus bearing GFP cDNA.
Luciferase Reporter Assays for ␥-Cleavage. ␥-Secretase cleavage of APP or Notch was determined as the ratio between the luciferase activities of the ␥-secretase-dependent variant (APP⌬C99-Gal4-VP16, Notch⌬E-Gal4-VP16) and the mean luciferase activities of the ␥-secretase-independent signal obtained with Gal4-VP16.
Results
Targeted Inactivation of the Three Mouse Aph1 Genes. Aph1 deficient (Aph1 Ϫ/Ϫ ) mice were generated by homologous recombination (Fig. 6 , which is published as supporting information on the PNAS web site). The Aph1A gene was targeted conditionally with loxP sequences in intron 2 and intron 8 (Aph1A flx ). Subsequent Cre-mediated excision of the region between the loxP sites generated an Aph1A null allele (Aph1A Ϫ see Fig. 6A ). To inactivate Aph1B, an alkaline phosphatase reporter sequence was inserted in frame in exon 1. A neomycin resistance gene was inserted in intron 2. This Aph1B construct was electroporated into wild-type ES cells and in the ES cell line with one Aph1C allele already conditionally targeted ( 
Destabilization of the ␥-Secretase Components in the Absence of
Aph1A. Successful targeting of the three genes was confirmed at the DNA and the mRNA level by using Southern and RT-PCR experiments ( Fig. 7 , which is published as supporting information on the PNAS web site). We also confirmed the knockout of the different Aph genes by Western blotting of fibroblasts derived from knockout animals ( Fig. 1 ). Aph1A is absent from Aph1A Ϫ/Ϫ cells and staining with Aph1BC antibodies demonstrated that no major compensatory up-regulation of Aph1B and -1C protein occurs. (Fig. 1 A, the antibodies do not discriminate between the highly similar Aph1B and Aph1C protein). Similarly, no significant compensatory up-regulation of Aph1A is observed in the Aph1B Ϫ/Ϫ , the Aph1C Ϫ/Ϫ , or the double Aph1BC Ϫ/Ϫ fibroblast cell lines (Fig. 1B) . When Aph1C Ϫ/Ϫ -protein extracts were probed with the Aph1BC antibodies, a reduced signal is observed, reflecting the residual presence of Aph1B protein. In the Aph1B Ϫ/Ϫ cell line, a (weak) residual Aph1C staining is also observed after longer exposure of the blot (Fig. 1B Inset) . Accordingly, in the Aph1BC Ϫ/Ϫ double-deficient cell line, no specific staining is seen with Aph1BC antibodies. We conclude that all three Aph1 genes are expressed at the protein level in embryonic fibroblasts and that a full knockout of each of the three genes is obtained.
We analyzed membrane fractions from the different cell lines for the expression of the different ␥-secretase components. Only deficiency of Aph1A had a significant effect on Nct glycosylation and Nct, Pen2, and Psen expression levels ( Fig. 1C) , whereas Aph1B, Aph1C, or Aph1BC deficiency had little or no effects on the other ␥-secretase complex proteins (Fig. 8 , which is published as supporting information on the PNAS web site). The latter probably reflects the relative low expression of the Aph1BC proteins in these cells, because overexpression of transfected Aph1C in Aph1A Ϫ/Ϫ cells restored complex formation (results not shown).
We extended our biochemical analysis also to tissues in vivo, confirming deficient ␥-secretase complex assembly in yolk sac and embryo proper (Fig. 1D ). The value in parentheses indicates five additional Aph1A Ϫ͞Ϫ embryos that were recovered but probably dead (as defined by no beating heart).
found (Fig. 2F) . Compared to mice with a complete loss of ␥-secretase activity (Psen1&2 Ϫ/Ϫ or Nct Ϫ/Ϫ ), the caudal body axis at E10.5 extends significantly further, and regular hind limb buds and a short stretch of the tail anlage are observed.
Angiogenesis. The Aph1A Ϫ/Ϫ mice fail to develop an organized vascular system in their yolk sacs. At E10.5, only isolated blood-forming islands or short Y-shaped vascular fragments were observed (Fig. 2 A-D) . Calibre irregularities and patterning defects are also seen in the intersomitic aortic branches (Fig. 2  G and K) . Heart looping occurs in the correct orientation (Fig.  2G) , but is inconstantly accompanied by a distended pericardial sac as in Psen double-deficient mice (data not shown).
Somitogenesis. Aph1A
Ϫ/Ϫ embryos display normal embryonic turning (Fig. 2F) . In contrast to Psen1͞Psen2 Ϫ/Ϫ or Nct Ϫ/Ϫ mice, in which somite formation is characteristically abrogated after the fourth to fifth rostral somite pair (i.e., at the forelimb bud level), somite segmentation in Aph1A Ϫ/Ϫ mice goes on up to at least the hind limb buds (Fig. 2 G and I) . Although the bilateral symmetric segmentation appears to be intact, the somites are smaller than normal and feature a shallow, less regular external contour bulging beneath the surface ectoderm (Fig. 2I) . The latter correlates with a less well organized dermatomyotome and a high proportion of apoptotic cells in the sclerotome (Fig. 2K) .
Neural Tube. From E8.5, on neural tube ''kinking'' is observed (Fig. 3B) . From E9.5 onwards, the growth of the telencephalon anlage is visibly retarded, evidenced by either absent or hypoplastic hemispheric vesicles (Fig. 2F) . The strictly radial orientation of neuroepithelial cells in the neural tube is severely disturbed (Fig. 3 D and E) , and numerous cells emigrate into the surrounding mesoderm (Fig. 3D) . In addition, cells with pyknotic nuclei or extensive surface blebbing, both indicative of apoptosis, are encountered in the neuroepithelium (Fig. 3E ) and the surrounding mesoderm (Fig. 3G) . Apoptotic cell death was confirmed by immunostaining for cleaved caspase 3 (Fig. 3I) . It should be noticed that also large areas existed in the neuronal tube and mesoderm in which no overt signs of cell death could be identified.
Taken together, the loss of Aph1A leads to a mosaic phenotype that combines traits of a full loss of ␥-secretase deficiency (yolk sac) with that of a partial deficit (somitogenesis). Additional in situ hybridization experiments on embryos confirmed the strong expression of Aph1A in yolk sac and embryo proper which largely overlapped with the expression of the other ␥-secretase components Psen1, Pen2, and Nct (Fig. 9 , which is published as supporting information on the PNAS web site). Normal Overall Phenotype of Aph1B-and Aph1C-Deficient Mice. The Aph1B Ϫ/Ϫ , Aph1C Ϫ/Ϫ , and Aph1BC Ϫ/Ϫ homozygous mice were viable and fertile, and offspring derived from heterozygous crosses were born in normal Mendelian ratios (Table 1) . Preliminar microscopical inspection of tissues that express relatively high levels of Aph1B and Aph1C like brain, kidney, and testis (11) did not reveal any significant aberrations (results not shown).
APP and Notch Processing Are Equally Affected by the Absence of
Aph1A. We next analyzed the effect of the different Aph1 deficiencies on ␥-secretase activity in the embryonic fibroblasts by evaluating the levels of endogenous APP and N-cadherin (N-Cad) C-terminal fragments (CTF). These fragments are the direct substrates for ␥-secretase and they accumulate when this activity is decreased. In agreement with the embryonic phenotype, only in Aph1A Ϫ/Ϫ fibroblasts could accumulation of APP-CTF and N-Cad-CTF be demonstrated (Fig. 4A) . It should be noticed that a decreased expression of full-length APP is observed as well, which could indicate a regulatory loop between APP-CTF accumulation (or inhibition of APP intracellular domain generation) and APP steady state levels of expression (19) . An important question is whether any of the Aph1 components differentially contribute to the cleavage of APP or Notch. Therefore, we transduced fibroblasts with human APP or with a Notch⌬E construct and measured directly the generation of A␤ peptide or NICD (Fig. 4 B and C) . Aph1A deficiency dramatically inhibited both APP and Notch processing. Although A␤ generation seemed to be more strongly affected than NICD release (Fig. 4B , row indicated with A␤, and 4C, row indicated with NICD), these assays rely on different antibodies, making it difficult to compare them directly. Therefore, we transfected fibroblasts with a UAS-luciferase reporter gene and an APP or a Notch reporter construct that include a Gal4-VP16 sequence in their cytoplasmic domains. In this experiment, the only variable is the transmembrane domain, and readout can therefore directly be compared for the two substrates. In this assay (Fig. 4D) , both APP and Notch processing are affected to a similar extent by Aph1A deficiency (Ϸ70% inhibition).
Alterations in APP Processing in Aph1BC ؊/؊ Adult Brain. From our previous work, we know that Aph1BC is expressed relatively more abundantly in brain (11) . Therefore, we analyzed the repercussions of Aph1BC Ϫ/Ϫ deficiency in different regions of adult brain on expression of the other ␥-secretase subunits and APP processing (as reflected by changes in APP-CTF levels; Fig. 5 ).
The absence of Aph1BC affected Psen1 and Pen2 steady state levels (most clearly seen in the brainstem extracts). Aph1A 
Discussion
The three rodent Aph1 genes were successfully targeted by homologous recombination as demonstrated by Southern blotting and RT-PCR analysis of the different mouse lines obtained. The absence of protein expression was confirmed by Western blotting. The Aph1A Ϫ/Ϫ mice display an embryonic lethal phenotype, whereas the Aph1B Ϫ/Ϫ and Aph1C Ϫ/Ϫ mice display a normal phenotype with no gross abnormalities in fertility, survival, or anatomy. In that regard, they are even less affected than the Psen2 Ϫ/Ϫ mice, which have also a quite normal overall phenotype, but suffer from lung hemorrhages and fibrosis in adulthood (20) (21) (22) . It should be noted that Aph1B and Aph1C are highly similar (96.3% at the nucleotide level) and that both genes are clustered on chromosome 9. Most likely, they arose by rodent-specific gene duplication (11, 23) . Because both genes are actively transcribed (shown here), we targeted the two genes consecutively on the same chromosome. The AphBC Ϫ/Ϫ was also compatible with survival into adulthood and further breeding. However, at the biochemical level, the Aph1BC Ϫ/Ϫ mice displayed a very interesting phenotype, showing accumulation of APP-CTF in specific regions of the adult mouse brain. Such an accumulation of APP-CTF indicates deficient ␥-secretase processing, as has been demonstrated in various Psen-and Nctdeficient mice and cell lines (21, 24, 25) .
A question that needs to be addressed here is whether the quite spectacular ''loss of Aph1A function'' phenotype can entirely be explained by an impaired ␥-secretase activity. The vascular reorganization deficits in the yolk sac have been observed in the severe loss of function of ␥-secretase seen in Psen1&2 Ϫ/Ϫ mice (20, 21) and Nct Ϫ/Ϫ mice (24). Two other major features of the Aph1A Ϫ/Ϫ phenotype (apoptosis and neuroepithelial emigration from the neural tube) have previously not been recognized but are also aspects of severe ␥-secretase deficiency, as we observed when reinvestigating our Psen1&2 Ϫ/Ϫ mice (T.T. and D.H., unpublished observations). In contrast, somite segmentation, which is severely affected in Psen1&2 Ϫ/Ϫ mice, appears to be relatively preserved in the Aph1A Ϫ/Ϫ mice. Because a severe defect of body axis extension and mesoderm segmentation is also seen in Nct Ϫ/Ϫ mice (24), it is reasonable to conclude that the relative mild effects of the Aph1A deficiency on somitogenesis reflect a residual level of ␥-secretase activity in this tissue that is sufficient to maintain at least partially the Notch-driven segmentation clock (26) . It should be noted that the somites of a Notch-1 processing deficient mouse that was generated by mutating the ␥-secretase (S3) cleavage site were also only moderately affected (27) , suggesting that relatively low levels of (cleavage dependent) Notch signaling are sufficient to maintain this developmental process. The conclusion that Aph1A deficiency reflects essentially impaired ␥-secretase function is further confirmed by in situ hybridization experiments demonstrating the overlap in expression of Aph1A and other ␥-secretase components (Fig. 9) , and the biochemical analysis demonstrating the decreased expression of the other ␥-secretase components in Aph1A Ϫ/Ϫ yolk sac and embryo proper (Fig. 1D) . However, we cannot completely rule out the theoretical possibility that Aph1A exerts also more subtle non-␥-secretase functions that remain to be discovered.
The loss of ␥-secretase component expression in Aph1A
fibroblasts apparently causes an Ϸ70% reduction in ␥-secretase activity (Fig. 4D ). This decrease roughly corresponds to the activity of a single Psen1 knockout, whereas the phenotypical alterations are more similar to the severe phenotype observed in Psen1&2 Ϫ/Ϫ embryos that are 100% deficient in ␥-secretase processing. It has to be left open for the moment whether these differences in the Aph1A and Psen1 null phenotypes are due to subtle differences in the activity of Psen1 deficient versus Aph1A-deficient ␥-secretase complexes in vivo that were not readily seen in the fibroblast cell culture analysis. Alternatively, subtle differences in tissue expression of the different isoforms of the ␥-secretase complex, with, for example, Aph1A complexes playing a key role in vasculogenesis, could explain the observed heterogeneity in function of the different ␥-secretase complexes. A third important point are the specific deficiencies in ␥-secretase processing of APP observed in the brain of Aph1BC-deficient mice. These results are in line with recent findings in a rat model for neurodevelopmental disorders (23) . In these rats, a genetic recombination event in the Aph1B and -C locus resulted in diminished Aph1BC expression and changes in ␥-secretase cleavage activity in brain regions in a pattern quite similar to our observations in mice. These rats display several neurobehavioral abnormalities, like increased sensitivity to apomorphine, changes in prepulse and latent inhibition, and others (23) that segregate with the different levels of Aph1BC expression. Thus, from an Alzheimer's disease therapy point of perspective, the survival of Aph1BC-deficient mice into adulthood suggests that the Aph1BC-containing complexes might be a less problematic drug target than the Aph1A containing complexes, although the rat studies indicate that the repercussions have to be further evaluated at the psychopharmacological level. This situation is not very different from the BACE-1 target (28) . The Aph1A subgroup of ␥-secretase complexes in contrast has a central role in development, and is likely also involved in the main ␥-secretase functions in adulthood.
